Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Oct;81(3-4):81-3.
doi: 10.1007/s00239-015-9695-7. Epub 2015 Aug 20.

Cancer Molecular Evolution

David Posada  1
Affiliations
Editorial

Cancer Molecular Evolution

David Posada. J Mol Evol. 2015 Oct.
No abstract available

PubMed Disclaimer

References

    1. Aktipis CA, Kwan VS, Johnson KA, Neuberg SL, Maley CC. Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS One. 2011;6:e26100. doi: 10.1371/journal.pone.0026100. - DOI - PMC - PubMed
    1. Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, Velculescu VE, Vogelstein B, Nowak MA. Genetic progression and the waiting time to cancer. PLoS Comput Biol. 2007;3:e225. doi: 10.1371/journal.pcbi.0030225. - DOI - PMC - PubMed
    1. Beerenwinkel N, Schwarz RF, Gerstung M, Markowetz F. Cancer evolution: mathematical models and computational inference. Syst Biol. 2015;64:e1. doi: 10.1093/sysbio/syu081. - DOI - PMC - PubMed
    1. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA. 2010;107:18545. doi: 10.1073/pnas.1010978107. - DOI - PMC - PubMed
    1. Burrell RA, Swanton C. Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol Oncol. 2014;8:1095. doi: 10.1016/j.molonc.2014.06.005. - DOI - PMC - PubMed

Publication types

LinkOut - more resources